-
公开(公告)号:US20140224976A1
公开(公告)日:2014-08-14
申请号:US14242075
申请日:2014-04-01
Applicant: QUEST DIAGNOSTICS INVESTMENTS INC
Inventor: Scott GOLDMAN
CPC classification number: H01J49/0036 , G01N33/92 , G01N2560/00 , H01J49/0027 , H01J49/10 , H01J49/426 , Y10T436/20 , Y10T436/200833 , Y10T436/201666
Abstract: The invention relates to the detection of fatty acids. In a particular aspect, the invention relates to methods for detecting very long chain fatty acids and branched chain fatty acids by mass spectrometry.
Abstract translation: 本发明涉及脂肪酸的检测。 在一个特定方面,本发明涉及通过质谱法检测非常长链脂肪酸和支链脂肪酸的方法。
-
公开(公告)号:US20030092060A1
公开(公告)日:2003-05-15
申请号:US09999700
申请日:2001-10-31
Applicant: Quest Diagnostics Investments, Inc.
Inventor: Miller Phillip P. , Garrity Martha
IPC: G01N033/53 , G01N033/542 , C07D219/08 , C07K014/435 , C07K007/08
CPC classification number: C07D219/04 , C07D219/06 , G01N33/532
Abstract: A novel chemiluminescent compound is provided. In one embodiment, the novel compound is employed in an assay to detect analytes. The assay to detect analytes includes the steps of binding the novel compound to the analyte and detecting the novel compound.
Abstract translation: 提供了一种新颖的化学发光化合物。 在一个实施方案中,新化合物用于检测分析物的测定中。 检测分析物的测定包括将新化合物与分析物结合并检测新化合物的步骤。
-
公开(公告)号:US20240333856A1
公开(公告)日:2024-10-03
申请号:US18739123
申请日:2024-06-10
Applicant: QUEST DIAGNOSTICS INVESTMENTS INC.
Inventor: John Koehl
IPC: H04N1/327 , G06F3/12 , G06V30/413 , G16H20/10 , G16H30/40 , G16H40/67 , G16H70/20 , G16H70/40 , H04N1/00 , H04N1/23
CPC classification number: H04N1/32776 , G06F3/1292 , G06V30/413 , G16H20/10 , G16H30/40 , G16H40/67 , G16H70/20 , G16H70/40 , H04N1/00307 , H04N1/00344 , H04N1/2361 , H04N2201/0046 , H04N2201/0055 , H04N2201/3253
Abstract: Systems and methods are provided through which a transaction, e.g., in a multi-tier, distributed application may be initiated from a portable or hand-held device, such as a smartphone. A computer system or systems, possibly remote from the device, may approve the transaction, complete it, or both, and the remote computer system or systems may cause a document to be printed, e.g., by a printer physically proximate to the device.
Aspects of the invention are illustrated by embodiments in which a drug prescription may be created electronically using a hand-held device. In such an embodiment, the prescription may be transmitted to one or more remote computer systems, such as an application server, for processing. If specified, the remote computer systems may cause a prescription to be printed, e.g., at a printer near the prescriber's location. The prescriber may sign the printed prescription and give it to a patient or pharmacy.-
公开(公告)号:US11669228B2
公开(公告)日:2023-06-06
申请号:US17346843
申请日:2021-06-14
Applicant: QUEST DIAGNOSTICS INVESTMENTS INC.
Inventor: Peter Wilkinson , Kerry O'Brien
IPC: G06F3/0484 , G16H15/00 , G06F16/20 , G06F16/951 , G06F3/0482 , G06F3/04847
CPC classification number: G06F3/0484 , G06F3/0482 , G06F3/04847 , G06F16/20 , G06F16/951 , G16H15/00
Abstract: Computer systems and methods may display multi-dimensional data sets in a dynamically-generated ocular view, which may show the relationship between data points in the different dimensions. For example, such a data set may include in one dimension results of one or more laboratory tests and, in another dimension, body systems or functions that the respective tests may relate to. The ocular view may depict the relationships between the tests and the systems. By being generated dynamically, moreover, the ocular view may be able to present this information for arbitrary sets of test results, without a template having been generated in advance to specify the layout of some particular combination of results.
-
公开(公告)号:US11036369B2
公开(公告)日:2021-06-15
申请号:US16735196
申请日:2020-01-06
Applicant: QUEST DIAGNOSTICS INVESTMENTS INC.
Inventor: Peter Wilkinson , Kerry O'Brien
IPC: G06F3/0484 , G16H15/00 , G06F16/20 , G06F16/951 , G06F3/0482
Abstract: Computer systems and methods may display multi-dimensional data sets in a dynamically-generated ocular view, which may show the relationship between data points in the different dimensions. For example, such a data set may include in one dimension results of one or more laboratory tests and, in another dimension, body systems or functions that the respective tests may relate to. The ocular view may depict the relationships between the tests and the systems. By being generated dynamically, moreover, the ocular view may be able to present this information for arbitrary sets of test results, without a template having been generated in advance to specify the layout of some particular combination of results.
-
公开(公告)号:US10818388B2
公开(公告)日:2020-10-27
申请号:US15905514
申请日:2018-02-26
Applicant: Quest Diagnostics Investments Inc.
Inventor: Richard A. Mahoney , Thomas R. Wagner
Abstract: The invention relates to the administration of prescription drug formulary information. A list of drugs that a particular prescription drug plan will pay for in whole or in part is called a formulary. The invention involves the use of information and customizable rules associated with formularies, combined with information from patient medical records, to generate custom, dynamic formularies applicable to specific patients, groups of patients, or both. Depending on the choice of rules and the other information, this may help payers control prescription drug costs by encouraging the use of less-expensive drugs when medically appropriate, but without impairing the freedom of prescribers to prescribe specific drugs according to their professional judgments. Some embodiments may also be adapted to generate and store data about the use and functioning of the embodiments or aspects of them and to generate reports containing some or all such data in response to queries.
-
公开(公告)号:US20200162634A1
公开(公告)日:2020-05-21
申请号:US16773376
申请日:2020-01-27
Applicant: QUEST DIAGNOSTICS INVESTMENTS INC.
Inventor: John Koehl
Abstract: Systems and methods are provided though which a transaction, e.g., in a multi-tier, distributed application may be initiated from a portable or hand-held device, such as a smartphone. A computer system or systems, possibly remote from the device, may approve the transaction, complete it, or both, and the remote computer system or systems may cause a document to be printed, e.g., by a printer physically proximate to the device.Aspects of the invention are illustrated by embodiments in which a drug prescription may be created electronically using a hand-held device. In such an embodiment, the prescription may be transmitted to one or more remote computer systems, such as an application server, for processing. If specified, the remote computer systems may cause a prescription to be printed, e.g., at a printer near the prescriber's location. The prescriber may sign the printed prescription and give it to a patient or pharmacy.
-
公开(公告)号:US10547761B2
公开(公告)日:2020-01-28
申请号:US16218269
申请日:2018-12-12
Applicant: QUEST DIAGNOSTICS INVESTMENTS INC.
Inventor: John Koehl
Abstract: Systems and methods are provided though which a transaction, e.g., in a multi-tier, distributed application may be initiated from a portable or hand-held device, such as a smartphone. A computer system or systems, possibly remote from the device, may approve the transaction, complete it, or both, and the remote computer system or systems may cause a document to be printed, e.g., by a printer physically proximate to the device.Aspects of the invention are illustrated by embodiments in which a drug prescription may be created electronically using a hand-held device. In such an embodiment, the prescription may be transmitted to one or more remote computer systems, such as an application server, for processing. If specified, the remote computer systems may cause a prescription to be printed, e.g., at a printer near the prescriber's location. The prescriber may sign the printed prescription and give it to a patient or pharmacy.
-
公开(公告)号:US20190124228A1
公开(公告)日:2019-04-25
申请号:US16218269
申请日:2018-12-12
Applicant: QUEST DIAGNOSTICS INVESTMENTS INC.
Inventor: John Koehl
CPC classification number: H04N1/32776 , G06F3/1292 , G06F19/00 , G06F19/326 , G06F19/3418 , G06F19/3456 , G06K9/00456 , G16H20/10 , G16H30/40 , H04N1/00307 , H04N1/00344 , H04N1/2361 , H04N2201/0046 , H04N2201/0055 , H04N2201/3253
Abstract: Systems and methods are provided though which a transaction, e.g., in a multi-tier, distributed application may be initiated from a portable or hand-held device, such as a smartphone. A computer system or systems, possibly remote from the device, may approve the transaction, complete it, or both, and the remote computer system or systems may cause a document to be printed, e.g., by a printer physically proximate to the device.Aspects of the invention are illustrated by embodiments in which a drug prescription may be created electronically using a hand-held device. In such an embodiment, the prescription may be transmitted to one or more remote computer systems, such as an application server, for processing. If specified, the remote computer systems may cause a prescription to be printed, e.g., at a printer near the prescriber's location. The prescriber may sign the printed prescription and give it to a patient or pharmacy.
-
公开(公告)号:US20180182477A1
公开(公告)日:2018-06-28
申请号:US15905514
申请日:2018-02-26
Applicant: Quest Diagnostics Investments Inc.
Inventor: Richard A. Mahoney , Thomas R. Wagner
CPC classification number: G16H20/00 , G06F19/328 , G06F19/3456 , G06Q30/06 , G06Q40/08 , G06Q50/22 , G06Q50/24 , G16H20/10 , G16H80/00
Abstract: The invention relates to the administration of prescription drug formulary information. A list of drugs that a particular prescription drug plan will pay for in whole or in part is called a formulary. The invention involves the use of information and customizable rules associated with formularies, combined with information from patient medical records, to generate custom, dynamic formularies applicable to specific patients, groups of patients, or both. Depending on the choice of rules and the other information, this may help payers control prescription drug costs by encouraging the use of less-expensive drugs when medically appropriate, but without impairing the freedom of prescribers to prescribe specific drugs according to their professional judgments. Some embodiments may also be adapted to generate and store data about the use and functioning of the embodiments or aspects of them and to generate reports containing some or all such data in response to queries.
-
-
-
-
-
-
-
-
-